Article Information
PubMed
Published By
Print ISSN
Online ISSN
History
- Published online September 7, 2022.
Article Versions
- Latest version (August 11, 2022 - 11:08).
- Latest version (August 25, 2022 - 06:47).
- You are viewing the most recent version of this article.
Copyright & Usage
© 2022 by American Journal of Neuroradiology Indicates open access to non-subscribers at www.ajnr.org
Author Information
- P.M. Cogswella,
- J.A. Barakosc,
- F. Barkhofd,e,f,
- T.S. Benzingerg,h,
- C.R. Jack Jr.a,
- T.Y. Poussaintj,
- C.A. Rajig,i,
- V.K. Ramananb and
- C.T. Whitlowk,l
- aFrom the Departments of Radiology (P.M.C., C.R.J.)
- bNeurology (V.K.R.), Mayo Clinic, Rochester, Minnesota
- cDepartment of Radiology (J.A.B.), California Pacific Medical Center, San Francisco, California
- dDepartments of Radiology (F.B.)
- eNuclear Medicine (F.B.), VU University Medical Center, Amsterdam, the Netherlands
- fQueen Square Institute of Neurology and Centre for Medical Image Computing (F.B.), University College London, UK
- gDepartments of Radiology (T.S.B., C.A.R.)
- hNeurosurgery (T.S.B.)
- iNeurology (C.A.R.),Washington University School of Medicine, St. Louis, Missouri
- jDepartment of Radiology (T.Y.P.), Boston Children’s Hospital, Boston, Massachusetts
- kDepartments of Radiology (C.T.W.)
- lBiomedical Engineering (C.T.W.), Wake Forest School of Medicine, Winston-Salem, North Carolina
- Please address correspondence to Petrice M. Cogswell, MD, PhD, Mayo Clinic, 200 First St SW, Rochester, MN 55905; e-mail: Cogswell.petrice{at}mayo.edu
Altmetrics
Cited By...
Jump to section
Related Articles
Cited By...
- Clinical Role of Brain PET in Alzheimer Disease in the Era of Disease-Modifying Therapies
- Spontaneous haemorrhage in subdural hygroma in an Alzheimers patient on lecanemab
- Alzheimer Disease Anti-Amyloid Immunotherapies: Imaging Recommendations and Practice Considerations for Monitoring of Amyloid-Related Imaging Abnormalities
- Brain magnetic resonance imaging software to support dementia diagnosis in routine clinical practice: a barrier to adoption study in the National Health Service (NHS) England
- Donanemab outperformed Aducanumab and Lecanemab on cognitive, but not on biomarker and safety outcomes: systematic review, frequentist and Bayesian network meta-analyses
- Teaching NeuroImage: Severe Amyloid-Related Imaging Abnormalities After Anti-{beta}-Amyloid Monoclonal Antibody Treatment
- Monoclonal Antibodies: What the Diagnostic Neuroradiologist Needs to Know
- Antiamyloid Monoclonal Antibody Therapy for Alzheimer Disease: Emerging Issues in Neurology
- Implications of the Approval of Lecanemab for Alzheimer Disease Patient Care: Incremental Step or Paradigm Shift?
- Brain Shrinkage in Anti-{beta}-Amyloid Alzheimer Trials: Neurodegeneration or Pseudoatrophy?
- CAA-ri and ARIA: Two Faces of the Same Coin?
- Reply:
- MRI Monitoring of Anti-Alzheimer Therapy Amyloid-Related Imaging Abnormalities: Due Diligence or Overkill?